A miR-146b-3p-based nanotherapeutic strategy rescues mitochondrial dysfunction and neurodegeneration in Parkinson’s disease models

Extracellular vesicles (EVs) derived from stem cells hold therapeutic promise due to their bioactive cargo in neurodegenerative disorders, including Parkinson's disease (PD). This study investigated the neuroprotective effects of EVs derived from skin-derived precursor cell-differentiated Schwann cells (SKP-SC-EVs) in PD models. SKP-SC-EVs protected SH-SY5Y cells and primary neurons from MPP⁺-induced cytotoxicity by restoration of mitochondrial functions in vitro. In MPTP-induced PD mice, intranasal administration of SKP-SC-EVs mitigated dopaminergic neuron loss in the substantia nigra, improved motor and olfactory deficits, and attenuated mitochondrial dysfunction in the midbrain. Untargeted metabolomics revealed that SKP-SC-EVs upregulated tricarboxylic acid cycle metabolites, notably nicotinamide adenine dinucleotide (NADH), and restored the expression of key NADH-generating enzymes. Furthermore, we identified miR-146b-3p as a highly enriched and functional miRNA within SKP-SC-EVs, sufficient to mimic the EV's protective effects on mitochondrial function. Finally, to address delivery challenges, we engineered a TAT peptide-modified nanoliposome (Lip@PEI/miR-146b-3p) for enhanced brain accumulation. This system successfully delivered miR-146b-3p to dopaminergic neurons, replicated the neuroprotective and metabolic benefits of SKP-SC-EVs in vivo, and reduced α-synuclein aggregation. Collectively, our findings demonstrate that SKP-SC-EVs exert neuroprotection via miR-146b-3p-mediated enhancement of mitochondrial metabolism, and that an engineered nanoliposome containing this miRNA represents a potential strategy for PD treatment.

Authors

Institutions

Publication Details

Journal
Regenerative Biomaterials
Published
2026-11-20
DOI
https://doi.org/10.1093/rb/rbag239
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A miR-146b-3p-based nanotherapeutic strategy rescues mitochondrial dysfunction and neurodegeneration in Parkinson’s disease models

李灵玲, Xiong Liu, Xi Wang, Mi Shen et al.
Regenerative Biomaterials
Extracellular vesicles in disease
article

A miR-146b-3p-based nanotherapeutic strategy rescues mitochondrial dysfunction and neurodegeneration in Parkinson’s disease models

李灵玲, Xiong Liu, Xi Wang, Mi Shen, Qingyu Zhang, Ying Qin, Qi Zhang, Jiali Wan, Feng Yun, Fei Ding
article en

Abstract

Extracellular vesicles (EVs) derived from stem cells hold therapeutic promise due to their bioactive cargo in neurodegenerative disorders, including Parkinson's disease (PD). This study investigated the neuroprotective effects of EVs derived from skin-derived precursor cell-differentiated Schwann cells (SKP-SC-EVs) in PD models. SKP-SC-EVs protected SH-SY5Y cells and primary neurons from MPP⁺-induced cytotoxicity by restoration of mitochondrial functions in vitro. In MPTP-induced PD mice, intranasal administration of SKP-SC-EVs mitigated dopaminergic neuron loss in the substantia nigra, improved motor and olfactory deficits, and attenuated mitochondrial dysfunction in the midbrain. Untargeted metabolomics revealed that SKP-SC-EVs upregulated tricarboxylic acid cycle metabolites, notably nicotinamide adenine dinucleotide (NADH), and restored the expression of key NADH-generating enzymes. Furthermore, we identified miR-146b-3p as a highly enriched and functional miRNA within SKP-SC-EVs, sufficient to mimic the EV's protective effects on mitochondrial function. Finally, to address delivery challenges, we engineered a TAT peptide-modified nanoliposome (Lip@PEI/miR-146b-3p) for enhanced brain accumulation. This system successfully delivered miR-146b-3p to dopaminergic neurons, replicated the neuroprotective and metabolic benefits of SKP-SC-EVs in vivo, and reduced α-synuclein aggregation. Collectively, our findings demonstrate that SKP-SC-EVs exert neuroprotection via miR-146b-3p-mediated enhancement of mitochondrial metabolism, and that an engineered nanoliposome containing this miRNA represents a potential strategy for PD treatment.

Regenerative Biomaterials
Nantong University (CN), Second People's Hospital of NanTong (CN)
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon